S1910 Differential Effect of Cardiometabolic Risk Factors on Mortality in US Adults With Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD)

Matthew Dukewich,Jennifer L. Dodge,Liyun Yuan,Norah A. Terrault
DOI: https://doi.org/10.14309/01.ajg.0001037008.48544.06
2024-10-26
The American Journal of Gastroenterology
Abstract:Metabolic dysfunction-associated steatotic liver disease (MASLD) is defined by abnormalities in cardiometabolic risk factors (CMRF), emphasizing a shared pathophysiology. Characterizing the influence of individual CMRFs on mortality among persons with MASLD can inform our understanding of clinical trajectory and phenotypes and guide prioritization of interventions to mitigate risk.
gastroenterology & hepatology
What problem does this paper attempt to address?